Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles (EVs): Technologies & Biological Investigations

Clayton Deighan's Biography



Clayton Deighan, North American Sales and Applications Manager, NanoFCM

Dr. Clayton Deighan completed his PhD in Dr. Jeff Chalmers lab at Ohio State in 2015 and has spent the years since working with EV investigators around the world on characterization of single EVs. He has now joined NanoFCM as the leader of their applications and sales teams in North America and is excited to bring their EV detection technologies to researchers around the world.

Clayton Deighan Image

The ExoView R200 Platform for Single EV and Virus Phenotyping and Sizing

Tuesday, 14 December 2021 at 17:30

Add to Calendar ▼2021-12-14 17:30:002021-12-14 18:30:00Europe/LondonThe ExoView R200 Platform for Single EV and Virus Phenotyping and SizingExtracellular Vesicles (EVs): Technologies and Biological Investigations in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

NanoView recently launched the ExoView R200, our latest analytical platform for purification-free analysis of extracellular vesicles and viruses. ExoView works by affinity capturing exosomes onto a protein microarray (ExoView chip) via common or custom exosomal markers. Once bound to the surface of the ExoView chip each individual exosome can be sized, counted and characterized in terms of protein expression. The latest R200 platform adds an additional fluorescent channel and EVs can now imaged in 4 fluorescent channels (blue, green, red and far-red) meaning that individual exosomes can be phenotyped by up to 5 surface or cargo proteins (4 fluorescent and 1 capture antibody) with single-molecule sensitivities. To complement the new platform, NanoView will also be discussing existing and new assays designed to enable EV and virus research. Standard assays as designed to measure common EV markers from cell culture or plasma samples (with or without purification) and can be extended to detect EV cargo which will be demonstrated. These assays have been optimized to promote biomarker colocalization on even the smallest EVs and have been extended to include fully user customizable assays that allow customers to capture and detect EVs via any custom protein of their choice. We will review newly developed assays for detecting lenti-viruses and their capsids.


Add to Calendar ▼2021-12-13 00:00:002021-12-15 00:00:00Europe/LondonExtracellular Vesicles (EVs): Technologies and Biological InvestigationsExtracellular Vesicles (EVs): Technologies and Biological Investigations in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com